Program

The program of the Autumn School consists of lectures by invited speakers as well as presentations of submitted abstracts by participants. Because of this we ask all participants to take an active part during the three-day event.

To submit an abstract and become a participant of the 3rd AEK Autumn School, please click here.

Download Programm…

6 November 2017

11:00 – 12:00   Registration & Coffee
12:00 – 13:00   Klaus Pantel (Hamburg)
Circulating Tumor Cells for Liquid Biopsy
13:00 – 13:30 Als PDF herunterladen Fabian Franke (München)
The tumor suppressor SASH1 interacts with the signal adaptor CRKL to inhibit epithelial-mesenchymal transition and metastasis formation
13:30 – 14:00   Coffee Break
14:00 – 15:00   Christoph Klein (Regensburg)
Early cancer cell dissemination and metastasis formation
15:00 – 15:30 Als PDF herunterladen Annabell Szymansky (Berlin)
Development and validation of targeted sequencing and minimal residual disease assays for risk stratification of neuroblastoma patients
15:30 – 16:00 Als PDF herunterladen Anja Rabien (Berlin)
Characteristics of invasive tumor cells in clear cell renal cell carcinomas
16:00 – 16:30   Coffee Break
16:30 – 17:30   Thomas Brabletz (Erlangen)
Cellular Plasticity in Cancer: driving force and therapeutic target
17:30 – 18:00 Als PDF herunterladen Miodrag Guzvic (Regensburg)
Molecular characterization of EpCAM-positive disseminated cancer cells in prostate cancer
18:00 – 18:30 Als PDF herunterladen Anna Schwinn (Erlangen)
Cancer cell plasticity in the absence of the EMT activator Zeb1
18:30 – 19:00 Als PDF herunterladen Maximilian Ehrenfeld (Munich)
The role of the adaptor protein CKRL in EMT and metastasis
19:00   Extended Poster Session with Finger Food and Drinks

7 November 2017

9:00 – 10:00   Ulrike Stein (Berlin)
Cancer Metastasis: Biomarkers, Networks, Interventions
10:00 – 10:30 Als PDF herunterladen Cathrin Ritter (Essen)
Merkel cell carcinoma derived miR-375 reprograms fibroblasts into MCC associated fibroblasts
10:30 – 11:00   Coffee Break
11:00 – 12:00   Judith Wahrheit (Innsbruck)
Tumor Metabolism
12:00 – 12:30 Als PDF herunterladen Isabell Frisch (Erlangen)
The role of the EMT transcription factor Zeb1 in early and late steps of pancreatic cancer
12:30 – 13:00 Als PDF herunterladen Johannes Müller (Munich)
Tumor supressor gene SASH1: a new essential factor for EMT and metastasis formation?
13:00 – 14:00   Lunch
14:00 – 15:00   Peter Friedl (Nijmegen)
Intravital microscopy: Plasticity of invasion and therapy response
15:00 – 15:30 Als PDF herunterladen Samantha Exner (Berlin)
The role of the EMT transcription factor Zeb1 in early and late steps of pancreatic cancer
15:30 – 16:00 Als PDF herunterladen Jan Gravemeyer (Essen)
The cell type specific function of JNK-1 in the development of hepatocellular carcinoma
16:00 – 16:30   Coffee Break
16:30 – 17:30   Björn Scheffler (Essen)
Target discovery and axploitation of oncogenic mechanisms in brain tumors
17:30 – 18:00 Als PDF herunterladen Ivelina Spassova (Essen)
Fibroblast plasticity and heterogeneity in skin cancer
18:00 – 18:30 Als PDF herunterladen Felix Tönisen (Nijmegen)
Molecular characterization of invading spheroid cultures reveals potential targets for invasion-associated radioresistance of melanoma
19:00   Dinner

8 November 2017

9:00 – 10:00   Thomas Krahn (Wuppertal, Berlin)
About the current IMI project Cancer-ID and an industry perspective about the use of disseminated tumor cells DNA/RNA for biomarker research and for cancer drug development.
10:00 – 13:00 Als PDF herunterladen Tessa Skroblyn (Berlin)
Developing in vitro and in vivo models to reveal the molecular and cellular mechanisms of testicular infiltration in pediatric ALL
10:30 – 11:00   Coffee Break
11:00 – 12:00   Ingeborg Tinhofer-Keilholz (Berlin)
Phenotyping of Circulating Tumor Cells
12:00 – 12:30 Als PDF herunterladen Christoph Barz (Munich)
Functional role of A4GALT, the Gb3/CD77 synthase in colorectal cancer cells
12:30 – 13:00 Als PDF herunterladen Christoph Sproll (Düsseldorf)
Immunohistochemical Detection of Lymph-Node DTCs in patients with node-negative Head and Neck Squamous Cell Carcinoma (pN0-HNSCC)
13:00 – 14:00   Award Ceremony, Lunch & Farwell